Researchers at Helmholtz Munich and the Technical University of Munich (TUM) have developed Nicheformer, the first large-scale foundation model that integrates single-cell analysis with spatial ...

Most potential oncology drugs fail during the drug development pipeline, even when there has been promising data for their efficacy during the in vitro stage. This makes it vital to identify in vitro ...

Billion dollar-backed AI drug developer, Xaira Therapeutics, has recently released the largest virtual cell model to-date to predict how cells respond to genetic perturbations in unseen biological ...